乌鸦传媒

Greater improvements over apremilast and placebo through 24 weeks

Philip Mease, MD, says this new instrument could be reliable in clinical practice

Philip Mease, MD, discusses real-world data presented at the ACR annual meeting

Late-onset PsA tied to worse functionality and more structural damage

Alexis Ogdie-Beatty, MD, says we need to turn to other items in our treatment toolbox

Health-related quality-of-life scores showed improvements as early as week 4

Philip Mease, MD, discusses the DISCOVER-2 abstracts presented at the ACR annual meeting